Filip Janku, M.D., Ph.D.« Back
Filip Janku, M.D., Ph.D. is an Associate Professor in the Department of Investigational Cancer Therapeutics (Phase I Program) at MD Anderson Cancer Center. His research focuses on proof-of-concept clinical trials that possess a pivotal correlative component especially those involving liquid biopsies, molecular profiling of cell-free DNA, and therapies targeting the PI3K, MAPK, IDH and KIT/PDGFR pathways and intratumor therapies. Dr. Janku received multiple awards for his research efforts, including Sidney Kimmel Scholar award, Khalifa Scholar Award, and several ASCO Merit Awards, as well as an American Association for Cancer Research Scholar-in-Training Award. He obtained his MD and PhD at the Charles University Prague.